Oleanolic acid improves pulmonary morphofunctional parameters in experimental sepsis by modulating oxidative and apoptotic processes

Respiratory Physiology and Neurobiology

Volumn 189, Issue 3, 2013, Pages 484-490

  Santos, Raquel Souza ^a   Silva, Pedro Leme ^a   de Oliveira, Gisele Pena ^a   Santos, Cintia Lourenço ^a   Cruz, Fernanda Ferreira ^a   de Assis, Edson Fernandes ^b   de Castro Faria Neto, Hugo Caire ^b   Capelozzi, Vera Luiza ^c   Morales, Marcelo Marcos ^a   Pelosi, Paolo ^d   Gattass, Cerli Rocha ^a   Rocco, Patricia Rieken Macedo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Chemokine; Cytokines; Dexamethasone; Histology; Lung mechanics; Oxidative stress

Indexed keywords

DEXAMETHASONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; OLEANOLIC ACID; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HISTOLOGY; INFLAMMATION; KIDNEY; LIGATION; LIVER; LUNG; LUNG LAVAGE; LUNG MECHANICS; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCTURE; SEPSIS; SHAM PROCEDURE;

CHEMOKINE; CYTOKINES; DEXAMETHASONE; HISTOLOGY; LUNG MECHANICS; OXIDATIVE STRESS;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CATALASE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; LUNG; MALE; MICE; MICE, INBRED BALB C; NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE II; OLEANOLIC ACID; OXIDATIVE STRESS; SEPSIS; SUPEROXIDE DISMUTASE;

EID: 84887988100     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2013.08.019     Document Type: Article

References (54)

1. Abdel-Zaher A.O., Abdel-Rahman M.M., Hafez M.M., Omran F.M. Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage. Toxicology 2007, 234:124-134.
2. Andaluz-Ojeda D., Bobillo F., Iglesias V., Almansa R., Rico L., Gandia F., Resino S., Tamayo E., de Lejarazu R.O., Bermejo-Martin J.F. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 2012, 57:332-336.
3. Andrades M., Ritter C., de Oliveira M.R., Streck E.L., Fonseca Moreira J.C., Dal-Pizzol F. Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress. J. Surg. Res. 2011, 167:e307-e313.
4. Annane D., Bellissant E., Bollaert P.E., Briegel J., Confalonieri M., De Gaudio R., Keh D., Kupfer Y., Oppert M., Meduri G.U. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. J. Am. Med. Assoc. 2009, 301:2362-2375.
5. Bates J.H., Decramer M., Chartrand D., Zin W.A., Boddener A., Milic-Emili J. Volume-time profile during relaxed expiration in the normal dog. J. Appl. Physiol. 1985, 59:732-737.
6. Bouazza Y., Sennoun N., Strub C., Regnault V., Gibot S., Meziani F., Lacolley P., Levy B. Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock. Intensive Care Med. 2011, 37:1857-1864.
7. Bowler R.P., Crapo J.D. Oxidative stress in allergic respiratory diseases. J. Allergy Clin. Immunol. 2002, 110:349-356.
8. Carnesecchi S., Deffert C., Donati Y., Basset O., Hinz B., Preynat-Seauve O., Guichard C., Arbiser J.L., Banfi B., Pache J.C., Barazzone-Argiroffo C., Krause K.H. A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid. Redox Signal. 2011, 15:607-619.
9. Chao M.C., Garcia C.S., de Oliveira M.B., Santos R.S., Lucas I.H., Silva P.L., Vieira-Abreu A., de Castro-Faria-Neto H.C., Parra-Cuentas E.R., Capelozzi V.L., Pelosi P., Rocco P.R. Degree of endothelium injury promotes fibroelastogenesis in experimental acute lung injury. Respir. Physiol. Neurobiol. 2010, 173:179-188.
10. Comhair S.A., Bhathena P.R., Farver C., Thunnissen F.B., Erzurum S.C. Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J. 2001, 15:70-78.
11. Comhair S.A., Erzurum S.C. Antioxidant responses to oxidant-mediated lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L246-L255.
12. Czock D., Keller F., Rasche F.M., Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin. Pharmacokinet. 2005, 44:61-98.
13. Dinis-Oliveira R.J., Duarte J.A., Sanchez-Navarro A., Remiao F., Bastos M.L., Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit. Rev. Toxicol. 2008, 38:13-71.
14. Engelhardt G. Effect of corticosteroids on the toxic pulmonary oedema induced by nitrogen dioxide inhalation in the rat. Arzneimittelforschung 1987, 37:519-523.
15. Fry D.E. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am. Surg. 2012, 78:1-8.
16. Greos L.S., Vichyanond P., Bloedow D.C., Irvin C.G., Larsen G.L., Szefler S.J., Hill M.R. Methylprednisolone achieves greater concentrations in the lung than prednisolone: a pharmacokinetic analysis. Am. Rev. Respir. Dis. 1991, 144:586-592.
17. Guo R.F., Ward P.A. Role of oxidants in lung injury during sepsis. Antioxid. Redox Signal. 2007, 9:1991-2002.
18. Gutteridge J.M., Mitchell J. Redox imbalance in the critically ill. Br. Med. Bull. 1999, 55:49-75.
19. Jaeschke R., Angus D.C. Living with uncertainty in the intensive care unit: should patients with sepsis be treated with steroids?. J. Am. Med. Assoc. 2009, 301:2388-2390.
20. Jantz M.A., Sahn S.A. Corticosteroids in acute respiratory failure. Am. J. Respir. Crit. Care Med. 1999, 160:1079-1100.
21. Ji H.Y., Shin B.S., Jeong D.W., Park E.J., Park E.S., Yoo S.D., Lee H.S. Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics. Arch. Pharm. Res. 2009, 32:251-257.
22. Kantar M., Kultursay N., Kutukculer N., Akisu M., Cetingul N., Caglayan S. Plasma concentrations of granulocyte-macrophage colony-stimulating factor and interleukin-6 in septic and healthy preterms. Eur. J. Pediatr. 2000, 159:156-157.
23. Kinnula V.L., Crapo J.D. Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med. 2003, 167:1600-1619.
24. Kong X., Thimmulappa R., Craciun F., Harvey C., Singh A., Kombairaju P., Reddy S.P., Remick D., Biswal S. Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. Am. J. Respir. Crit. Care Med. 2011, 184:928-938.
25. Landry D.W., Oliver J.A. The pathogenesis of vasodilatory shock. N. Engl. J. Med. 2001, 345:588-595.
26. Lang J.D., Matute-Bello G. Lymphocytes, apoptosis and sepsis: making the jump from mice to humans. Crit. Care 2009, 13:109.
27. Lang J.D., McArdle P.J., O'Reilly P.J., Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 2002, 122:314S-320S.
28. Lange M., Szabo C., Traber D.L., Horvath E., Hamahata A., Nakano Y., Traber L.D., Cox R.A., Schmalstieg F.C., Herndon D.N., Enkhbaatar P. Time profile of oxidative stress and neutrophil activation in ovine acute lung injury and sepsis. Shock 2012, 37:468-472.
29. Lee J.Y., Moon H., Kim C.J. Effects of hydroxy pentacyclic triterpene acids from Forsythia viridissima on asthmatic responses to ovalbumin challenge in conscious guinea pigs. Biol. Pharm. Bull. 2010, 33:230-237.
30. Liu J., Wu Q., Lu Y.F., Pi J. New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction. Biochem. Pharmacol. 2008, 76:922-928.
31. Marchant A., Deviere J., Byl B., De Groote D., Vincent J.L., Goldman M. Interleukin-10 production during septicaemia. Lancet 1994, 343:707-708.
32. Matute-Bello G., Frevert C.W., Kajikawa O., Skerrett S.J., Goodman R.B., Park D.R., Martin T.R. Septic shock and acute lung injury in rabbits with peritonitis: failure of the neutrophil response to localized infection. Am. J. Respir. Crit. Care Med. 2001, 163:234-243.
33. Olivant Fisher A., Husain K., Wolfson M.R., Hubert T.L., Rodriguez E., Shaffer T.H., Theroux M.C. Hyperoxia during one lung ventilation: inflammatory and oxidative responses. Pediatr. Pulmonol. 2012, 47:979-986.
34. Oliveira G.P., Oliveira M.B., Santos R.S., Lima L.D., Dias C.M., Ab' Saber A.M., Teodoro W.R., Capelozzi V.L., Gomes R.N., Bozza P.T., Pelosi P., Rocco P.R. Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis. Crit. Care 2009, 13:R74.
35. Orfanos S.E., Mavrommati I., Korovesi I., Roussos C. Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med. 2004, 30:1702-1714.
36. Pittet J.F., Lu L.N., Morris D.G., Modelska K., Welch W.J., Carey H.V., Roux J., Matthay M.A. Reactive nitrogen species inhibit alveolar epithelial fluid transport after hemorrhagic shock in rats. J. Immunol. 2001, 166:6301-6310.
37. Pollier J., Goossens A. Oleanolic acid. Phytochemistry 2012, 77:10-15.
38. Reinhart K., Bauer M., Riedemann N.C., Hartog C.S. New approaches to sepsis: molecular diagnostics and biomarkers. Clin. Microbiol. Rev. 2012, 25:609-634.
39. Reisman S.A., Aleksunes L.M., Klaassen C.D. Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Biochem. Pharmacol. 2009, 77:1273-1282.
40. Santos C.L., Moraes L., Santos R.S., Oliveira M.G., Silva J.D., Maron-Gutierrez T., Ornellas D.S., Morales M.M., Capelozzi V.L., Jamel N., Pelosi P., Rocco P.R., Garcia C.S. Effects of different tidal volumes in pulmonary and extrapulmonary lung injury with or without intraabdominal hypertension. Intensive Care Med. 2012, 38:499-508.
41. Santos R.S., Silva P.L., Oliveira G.P., Cruz F.F., Ornellas D.S., Morales M.M., Fernandes J., Lanzetti M., Valenca S.S., Pelosi P., Gattass C.R., Rocco P.R. Effects of oleanolic acid on pulmonary morphofunctional and biochemical variables in experimental acute lung injury. Respir. Physiol. Neurobiol. 2011, 179:129-136.
42. Siedlinski M., van Diemen C.C., Postma D.S., Vonk J.M., Boezen H.M. Superoxide dismutases, lung function and bronchial responsiveness in a general population. Eur. Respir. J. 2009, 33:986-992.
43. Soejima K., McGuire R., Snyder N.T., Uchida T., Szabo C., Salzman A., Traber L.D., Traber D.L. The effect of inducible nitric oxide synthase (iNOS) inhibition on smoke inhalation injury in sheep. Shock 2000, 13:261-266.
44. Song M., Hang T.J., Wang Y., Jiang L., Wu X.L., Zhang Z., Shen J., Zhang Y. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J. Pharm. Biomed. Anal. 2006, 40:190-196.
45. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., Xie Q.W., Nathan C., Gribble G.W., Sporn M.B. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 1998, 58:717-723.
46. Thakur S., Baydoun A.R. Post-transcriptional divergence in the regulation of CAT-2A, CAT-2B and iNOS expression by dexamethasone in vascular smooth muscle cells. Amino acids 2012, 43:667-676.
47. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 2006, 116:984-995.
48. Thimmulappa R.K., Scollick C., Traore K., Yates M., Trush M.A., Liby K.T., Sporn M.B., Yamamoto M., Kensler T.W., Biswal S. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-imidazolide. Biochem. Biophys. Res. Commun. 2006, 351:883-889.
49. Tsai S.J., Yin M.C. Anti-oxidative, anti-glycative and anti-apoptotic effects of oleanolic acid in brain of mice treated by d-galactose. Eur. J. Pharmacol. 2012, 689:81-88.
50. Uematsu S., Engelberts D., Peltekova V., Otulakowski G., Post M., Kavanagh B.P. Dissociation of inflammatory mediators and function: experimental lung injury in nonpulmonary sepsis. Crit. Care Med. 2013, 41:151-158.
51. Vincent J.L., Korkut H.A. Defining sepsis. Clin. Chest Med. 2008, 29:585-590.
52. Wang X., Ye X.L., Liu R., Chen H.L., Bai H., Liang X., Zhang X.D., Wang Z., Li W.L., Hai C.X. Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem. Biol. Interact. 2010, 184:328-337.
53. Watanabe K., Koizumi F., Kurashige Y., Tsurufuji S., Nakagawa H. Rat CINC, a member of the interleukin-8 family, is a neutrophil-specific chemoattractant in vivo. Exp. Mol. Pathol. 1991, 55:30-37.
54. Weibel E.R. Morphometry: stereological theory and practical methods. Microscopy and Structural Methods 1990, 199-247. Marcel Dekker, New York. J. Gil (Ed.).